Literature DB >> 637382

Primary lung cancer and asthma.

R M Ford.   

Abstract

6,021 40-year-old and older chronic asthma suffers, seen during the past 20 years, were analyzed with regard to the development of primary lung cancer and their smoking habits. Over this period only two developed lung cancer, 0.032% as compared with 0.314% in the general population. Only 16.9% of chronic asthmatics had smoked over any significant period during the five years prior to assessment as compared with approximately 40% of the general population. Of those who did smoke, the tendency was to a lesser extent. This survey adds further evidence that cancer develops less frequently in patients suffering from an allergic disease such as asthma, perhaps because of (1) some enhanced immunological activity preventing the advent of new growth or (2) reduced smoking habits of chronic asthmatics.

Entities:  

Mesh:

Year:  1978        PMID: 637382

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  5 in total

1.  History of allergy and atopic dermatitis in relation to squamous cell and Basal cell carcinoma of the skin.

Authors:  Judy Cheng; M Scot Zens; Eric Duell; Ann E Perry; M Shane Chapman; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-02-10       Impact factor: 4.254

2.  Natural killer cell activity in asthma.

Authors:  T Timonen; B Stenius-Aarniala
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

3.  Cutaneous response to intradermal histamine in lung cancer.

Authors:  G Cavigioli; B Mastropasqua; A Pelucchi; P Mazza; L Marazzini
Journal:  Agents Actions       Date:  1991-11

4.  Association between common allergic symptoms and cancer in the NHANES III female cohort.

Authors:  Young Kwang Chae; Stefan Neagu; Jongoh Kim; Athanasios Smyrlis; Mahasweta Gooptu; William Tester
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

5.  Decreased blood histamine levels in patients with solid malignant tumours.

Authors:  C Burtin; C Noirot; J Paupe; P Scheinmann
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.